Learn how label-free analysis can provide near real-time infectivity measurements for vaccines and viral-based gene therapies.
This week's Fierce LifeSci is brought to you by Catalent & LumaCyte. Trouble viewing? Click here. |
Date: Tuesday, January 26, 2021 Time: 11am ET / 8am PT Duration: 1 Hour |
|
Along with the complexities of vaccine and viral-based gene therapy process development comes the need for analytical techniques that can help assess quality parameters, especially in real-time. LumaCyte’s Laser Force Cytology (LFC) instrument, Radiance®, provides rapid and accurate measurement of quality attributes such as viral titer and infectivity, helping to accelerate the development and production of these advanced therapies. Join Catalent and LumaCyte to learn how: Label-free analysis can provide near real-time infectivity measurements Timely, cost-effective measurements help process optimization and scale-up LFC automates and accelerates viral titer and infectivity assays LFC results correlate with ddPCR, end-point dilution (TCID50) and plaque assays Register Now |
|
|
You are currently subscribed as newsletter@newslettercollector.com If you no longer wish to receive promotions from Fierce LifeSciences, simply unsubscribe. Refer to our Privacy Policy. Fierce LifeSciences is a division of Questex LLC. 685 3rd Ave 21st Floor New York, NY 10017 © 2020 Questex LLC. All Rights Reserved. Reproduction in whole or in part is prohibited without written permission. | |